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Abstract 21 
Single-piece silicone implants dominate metacarpophalangeal (MP) joint arthroplasty. The NeuFlex 22 
implant was introduced to improve on the clinical performance of other silicone implants by having a 23 
pre-flexed hinge. By visually examining a cohort of 30 explanted NeuFlex MP joint prostheses we 24 
sought to identify failure modes of these implants. Seven were not fractured, 11 had fractured across 25 
the hinge, nine had fractured at the junction of the distal stem and the hinge, and three showed 26 
fractures at both the hinge and at the junction of the distal stem and the hinge. This data may prove 27 
helpful with identifying how the performance of single-piece silicone implant designs can be improved. 28 
Level IV 29 
 30 
 31 
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INTRODUCTION 33 
 34 
Single-piece silicone implants dominate finger arthroplasty of the metacarpophalangeal (MP) joint.  35 
The Swanson (Wright Medical, Memphis, USA) implant is the market leader 36 
(Norwegian_Arthroplasty_Register, 2016).  Known ‘problems’ include fracture (Kimani et al., 2009), 37 
primarily at the junction of the distal stem and hinge (Joyce and Unsworth, 2002).  This position of 38 
fracture is also seen with the Avanta/Sutter (Sutter Corporation/Avanta, San Diego, USA) single-piece 39 
silicone finger implant (Joyce et al., 2003). It is thought to be particularly related to the dominance of 40 
subluxing forces in the rheumatoid MP joint (Drayton et al., 2016; Joyce, 2009).  In 1998 the pre-flexed 41 
NeuFlex implant was introduced.   The three designs, Swanson, Sutter and NeuFlex, are shown in Fig 42 
1.   43 
It is recognised that fracture of silicone MP implants is common.  Trail et al. reported that two-thirds of 44 
1336 Swanson implants had fractured at 17 years follow-up (Trail et al., 2004).  Goldfarb and Stern 45 
reported that 67% of their Swanson implants and 52% of their Sutter implants had fractured at 14 46 
years follow-up (Goldfarb and Stern, 2003).  A fractured implant does not necessarily mean a clinical 47 
failure but recurrent symptoms are more likely with fractured implants (Trail et al., 2004).   48 
Clinically, it has been reported that the NeuFlex MP joint has produced an increased range of motion 49 
compared to use of the Swanson implant (Delaney et al., 2005).  This finding was also reported by 50 
Escott et al, although their patients implanted with a Swanson implant had better self-reported function 51 
and aesthetics (Escott et al., 2010).  While Namdari and Weiss reported 1/29 fractures in their cohort 52 
of NeuFlex implants (Namdari and Weiss, 2009), similar fracture rates between the NeuFlex and 53 
Swanson designs have been reported (Kimani et al., 2009).  When NeuFlex and Sutter implants were 54 
compared in the MP joint, two out of 78 NeuFlex and five out of 78 Sutter implants broke (Pettersson 55 
et al., 2006).   56 
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The aim of this study was to assess the failure of explanted NeuFlex implants and compare the results 57 
with established patterns for other one-piece silicone implants. 58 
 59 
METHODS AND MATERIALS 60 
NeuFlex MP joint explants were gathered as part of an ongoing retrieval programme.  Following 61 
removal the implants were cleaned with a brief immersion in Chlorhexidine for 30 mins and then 62 
washed in tap water.  The explants were photographed using a digital camera.  The position of 63 
fracture, if any, was noted.  We recorded patient demographics including the patient age, gender, 64 
underlying diagnosis, site of surgery and time in situ.  The implants were part of a consecutive series 65 
of explants for which patient demographic data were available.   66 
Based on the explant results (q.v.), we compared the thickness of the central hinge section of NeuFlex 67 
and Sutter/Avanta implants as a thinner section would probably fail quicker, as crack growth 68 
resistance is probably key to the longevity of these single-piece, silicone prostheses (ASTM-F1781-15, 69 
2015; Hutchinson et al., 1997).  Size 20 and size 40 implants of the NeuFlex and Sutter/Avanta were 70 
measured using a Vernier calliper (Mitutoyo, Huddersfield, UK).   71 
 72 
RESULTS 73 
Thirty NeuFlex MP joint explants were available for study.  The position of the complete implant 74 
fracture, if any, is shown in table 1, alongside patient and other information.  All revision procedures 75 
were undertaken for clinical problems i.e. symptomatic joint replacement failure requiring revision 76 
surgery after failure of non-operative treatment. 77 
Seven explants were not fractured (Fig 2A).  Eleven explants had completely fractured at the hinge 78 
(Fig 2B).  A further nine explants had completely fractured at the junction of the distal stem and hinge 79 
(Fig 2C).  Three explants had completely fractured at both the hinge and at the distal stem (Fig 2D).  80 
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We saw a mix of fractured and intact implants in some patients, for example explants 8-11 came from 81 
the hand of one patient.  One explant was intact, two had fractured at the distal stem and one had 82 
fractured at the hinge.  Separate to this we saw an explant (no. 19) with an incomplete fracture. 83 
NeuFlex MP explants ranged in size from 0 to 40.  As might be expected, smaller sizes were retrieved 84 
from the smaller fingers of hands, while larger implants tended to come from the index and middle 85 
fingers.  The age at revision ranged from 43 to 81 (median 58) years.  The time in situ ranged from 6 86 
to 120 (median 58.5) months.  In all but two cases the diagnosis was rheumatoid arthritis.  87 
Discolouration of some explants had occurred (Fig 3).  The significance of this is unclear but it could 88 
represent some change in material properties of the implant. 89 
The size 20 NeuFlex and Sutter/Avanta implants were each measured to have a hinge thickness of 90 
1.9 mm and the size 40 implants were each measured to have a hinge thickness of 2.3 mm. 91 
 92 
DISCUSSION 93 
As shown in table 1, 11 NeuFlex explants had fractured across the hinge (Fig 2B); this has not 94 
previously been reported in vivo.  Fracture at the hinge occurred when three NeuFlex implants were 95 
tested in vitro in a finger function simulator (Joyce and Unsworth, 2005).  Nine NeuFlex explants had 96 
fractured at the junction of the distal stem and hinge (Fig 2C).  This is similar to the site of implant 97 
fracture seen with Swanson implant fractures (Gellman et al., 1997; Trail et al., 2004) and 98 
Sutter/Avanta (Joyce et al., 2003) implant fractures.  In vitro tests have shown that Swanson (Joyce 99 
and Unsworth, 2000) and Sutter (Joyce et al., 2003) implants fracture at the junction of the distal hinge 100 
and stem, in both cases matching clinical experience.   101 
Intriguingly, 10% of the cohort fractured at the hinge and at the junction of the distal stem and hinge 102 
(Fig 2D).  The authors are not aware of such a failure mode having been reported previously.  That it 103 
happened in three explants, and that one of the un-fractured NeuFlex explants (no. 19) also showed 104 
substantial damage at both the hinge and the junction of the distal stem and hinge indicates that the 105 
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failure mode was not an anomaly; of greater note 11 (37%) fractured just at the hinge.  Overall 14 106 
(47%) suffered fractures of the implant hinge.  Silicone implant hinge fractures have not previously 107 
been reported.  It is unclear whether this occurs before, after or separate to stem fractures.   108 
The one incomplete fracture (no. 19) showed that fracture began dorsally.  This matches with the 109 
fracture initiation site of silicone MP joint implants seen previously (Joyce, 2009).   110 
Discolouration of most explants occurred (Fig 3) likely indicating that the silicone material can change 111 
when in the body.  This may affect the material properties of the implants and could therefore be a 112 
useful area for future research. 113 
We appreciate that fractures would likely have occurred sometime before removal of the implants and 114 
therefore time in situ does not equate with time to fracture. 115 
Ex vivo analysis of finger implants potentially highlight key areas of failure, thus providing information 116 
that could be used to reduce failures by improving future designs.  For example, based on the 117 
empirical evidence provided in this paper and by other previous publications (Drayton et al., 2016; 118 
Joyce, 2009; Joyce et al., 2003), subluxing forces need to be minimised, to reduce the shear stresses 119 
on the implant at both the junction of the distal stem and hinge and probably at the hinge.  In addition, 120 
consideration could be given to increasing the thickness of the hinge to reduce the time taken to 121 
fracture, although there may be a concomitant increase in stiffness of the implant. 122 
With improved designs, patients could achieve more with their replaced joints while increased 123 
prosthesis longevity should lead to fewer revision operations.  The latest Norwegian Arthroplasty 124 
Register shows that revision MP joint arthroplasties accounted for 42% of all MP joint replacement 125 
operations in 2015 (Norwegian_Arthroplasty_Register, 2016).  Therefore revision MP joint arthroplasty 126 
is common and opportunities to reduce such operations are substantial. 127 
There are limitations on this research.  There is no denominator to show the rate of implant failure.  128 
The details of the original operations are unknown; there may have been factors leading to implant 129 
failure.  There is no correlation with the biomechanics of the failed joints. 130 
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This study provides new data on the failure of NeuFlex implants raising questions about their design 131 
and its possible link to mechanical failure. 132 
 133 
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Figure legends 185 
Figure 1 – different designs of silicone single-piece finger implants.  Top NeuFlex, middle 186 
Sutter/Avanta, bottom Swanson.  In all cases the distal stem is to the right.   187 
Figure 2 A (top left) – An un-fractured NeuFlex explant (explant 15); B (top right) – A NeuFlex explant 188 
(explant 28) showing fracture at the hinge; C (bottom left) – A NeuFlex explant (explant 24) showing 189 
fracture at the junction of the distal stem and hinge; D (bottom right) – A NeuFlex explant (explant 13) 190 
showing fracture at both the hinge and at the junction of the hinge and the distal stem 191 
Figure 3 – Two NeuFlex explants (explant 18 above and explant 13 below) showing discolouration.  192 
Note that discolouration of explant 13 has occurred to the entire material and not just the outer 193 
surfaces.   194 
 195 
 196 
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 201 
Explant Finger Explant 
Size 
Patient 
age at 
revision 
Time in 
situ 
(months) 
Diagnosis Position of fracture 
1 Index 30 43 36 RA Hinge and distal stem 
2 Little 10 43 36 RA Hinge 
3 Middle 30 43 36 RA Hinge 
4 Index 40 58 63 RA Distal stem 
5 Middle 40 58 63 RA Distal stem 
6 Ring 30 58 63 RA Distal stem 
7 Little 20 58 63 RA Distal stem 
8 Index 30 78 54 RA Distal stem 
9 Middle 40 78 54 RA Distal stem 
10 Ring 20 78 54 RA No fracture 
11 Little 10 78 54 RA Hinge 
12 Ring 20 57 78 RA Hinge and distal stem 
13 Little 10 57 78 RA Hinge and distal stem 
14 Index 30 58 63 RA No fracture 
15 Ring 20 58 63 RA No fracture 
16 Little 20 58 63 RA No fracture 
17 Middle 40 58 63 RA Hinge 
18 Middle 40 84 18 OA Distal stem 
19 Index 40 84 18 OA No fracture 
20 Little 10 73 24 RA No fracture 
21 --- 40 70 120 RA Hinge 
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22 Little 10 62 18 RA Hinge 
23 Index 40 81 31 RA Distal stem 
24 Middle 40 81 31 RA Distal stem 
25 Little 20 81 31 RA No fracture 
26 Index 30 56 84 RA Hinge 
27 Middle 30 56 84 RA Hinge 
28 Ring 20 56 84 RA Hinge 
29 Little 0 56 84 RA Hinge 
30 Index 30 49 6 RA Hinge 
Table 1 – table of data regarding NeuFlex MP joint explants.  RA = rheumatoid arthritis; OA = 202 
osteoarthritis. 203 
 204 
